Search Results - "VAN GEEL, B. N"

Refine Results
  1. 1

    Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis by van Broekhoven, D. L. M., Verhoef, C., Elias, S. G., Witkamp, A. J., van Gorp, J. M. H. H., van Geel, B. A. N., Wijrdeman, H. K., van Dalen, T.

    Published in British journal of surgery (01-08-2013)
    “…Background Desmoid‐type fibromatosis is a locally aggressive soft tissue tumour with a biological behaviour that varies between relatively indolent and…”
    Get full text
    Journal Article
  2. 2

    Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma by Vrouenraets, Bart C, Hart, Guus A.M, Eggermont, Alexander M.M, Klaase, Joost M, van Geel, Bert N, Nieweg, Omgo E, Kroon, Bin B.R

    “…Background: The optimal toxic reaction of the normal tissues in perfused limbs after isolated limb perfusion (ILP) is unknown. Theoretically, more severe limb…”
    Get full text
    Journal Article
  3. 3

    Family history of breast cancer and local recurrence after breast-conserving therapy by Brekelmans, C.T.M, Voogd, A.C, Botke, G, van Geel, B.N, Rodrigus, P, Rutgers, E.J.Th, Klijn, J.G.M, Coebergh, J.W

    Published in European journal of cancer (1990) (01-04-1999)
    “…The impact of a family history of breast cancer on the local recurrence (LR) risk after breast-conserving therapy (BCT) was performed within the framework of a…”
    Get full text
    Journal Article
  4. 4

    Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs by Vrouenraets, B C, Eggermont, A M, Klaase, J M, Van Geel, B N, Van Dongen, J A, Kroon, B B

    Published in European journal of surgical oncology (01-12-1994)
    “…The incidence of long-term (> or = 3 months) neuropathy in 350 melanoma patients treated with single normothermic or 'mild' hyperthermic perfusion with…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Regional isolated perfusion with melphalan for patients with subungual melanoma by Vrouenraets, B C, Kroon, B B, Klaase, J M, van Geel, B N, Eggermont, A M, Mooi, W J, van Dongen, J A

    Published in European journal of surgical oncology (01-02-1993)
    “…From 1978 to 1990, 24 patients with subungual melanoma (MD Anderson Stage I, 17, Stage III, 7 patients) were treated with amputation of a digit and regional…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures by Dijstra, S, Wiggers, T, van Geel, B N, Boxma, H

    Published in The European journal of surgery (01-10-1994)
    “…Analysis of short-term and long-term complications after cemented osteosynthesis for pathological fractures. Retrospective study. South Municipal Hospital and…”
    Get more information
    Journal Article
  9. 9

    Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities by Klaase, J M, Kroon, B B, van Geel, B N, Eggermont, A M, Franklin, H R, Hart, G A

    Published in The American journal of surgery (01-06-1994)
    “…In order to gain some insight into the cause of acute regional toxicity after isolated perfusion using melphalan, 15 patient-related and…”
    Get more information
    Journal Article
  10. 10

    Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs by KLOP, W. M. C, VROUENRAETS, B. C, VAN GEEL, B. N, EGGERMONT, A. M. M, KLAASE, J. M, NIEWEG, O. E, KROON, B. B. R

    “…Melanoma recurring locoregionally after isolated limb perfusion (ILP) constitutes a therapeutic dilemma. Major amputation is a deterrent option for local…”
    Get full text
    Journal Article
  11. 11

    Systemic toxicity after isolated limb perfusion with melphalan for melanoma by Sonneveld, Eric J.A., Vrouenraets, Bart C., van Geel, Bert N., Eggermont, Alexander M.M., Klaase, Joost M., Nieweg, Omgo E., van Dongen, Joop A., Kroon, Bin B.R.

    Published in European journal of surgical oncology (01-10-1996)
    “…Systemic exposure to melphalan is minimized during isolated limb perfusion (ILP) by isolating a limb from the rest of the body. Consequently, there should be…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities by Vrouenraets, B C, Kroon, B B, Klaase, J M, Van Geel, B N, Eggermont, A M, Franklin, H R

    Published in Journal of surgical oncology (01-04-1993)
    “…From 1978 to 1990, 32 patients with Clark V melanoma were treated by wide excision of the primary and adjuvant regional isolated perfusion with melphalan. M.D…”
    Get more information
    Journal Article
  13. 13

    Intractible cutaneous non-Hodgkin's lymphoma of the lower limb. Complete remission after sequential regional isolated hyperthermic perfusion and perfusion with 1-phenylalanine-mustard (melphalan, L-Pam) by Jansen, R F, van Geel, B N, van der Zee, J, Hagenbeek, A, Levendag, P C

    Published in Cancer (15-07-1989)
    “…A 61-year-old man with an intractible and progressively disabling cutaneous non-Hodgkin's lymphoma (NHL) in the lower limb was treated with sequential regional…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions by Vrouenraets, B C, Klaase, J M, Kroon, B B, van Geel, B N, Eggermont, A M, Franklin, H R

    Published in Archives of surgery (Chicago. 1960) (01-01-1995)
    “…To determine the influence of acute regional toxic reactions on the incidence and characteristics of long-term morbidity after regional isolated perfusion with…”
    Get more information
    Journal Article
  16. 16

    Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma by van Dalen, Thijs, Hennipman, Adriaan, Van Coevorden, Frits, Hoekstra, Harald J, van Geel, Bert N, Slootweg, Piet, Lutter, Cherry F Albus, Brennan, Murray F, Singer, Samuel

    Published in Annals of surgical oncology (01-05-2004)
    “…The present AJCC/TNM staging system is of limited value for prediction of prognosis for patients with retroperitoneal sarcoma. The objective of the present…”
    Get full text
    Journal Article
  17. 17

    Temperature distribution and pH changes during hyperthermic regional isolation perfusion by van der Zee, J, Broekmeyer-Reurink, M P, van den Berg, A P, van Geel, B N, Jansen, R F, Kroon, B B, van Wijk, J, Hagenbeek, A

    “…Hyperthermic perfusion was given as a palliative treatment in three patients with a bulky tumour in the leg. During the treatment, temperature and pH data were…”
    Get more information
    Journal Article
  18. 18

    Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma by Noorda, Eva M, Takkenberg, Bart, Vrouenraets, Bart C, Nieweg, Omgo E, van Geel, Bert N, Eggermont, Alexander M M, Hart, Guus A M, Kroon, Bin B R

    Published in Annals of surgical oncology (01-05-2004)
    “…The influence of isolated limb perfusion (ILP) on the limb recurrence-free interval (LRFI) and the number of lesions per recurrence was studied for patients…”
    Get full text
    Journal Article
  19. 19

    Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST) by Brekelmans, C T, Voogd, A C, Botke, G, van Geel, B N, Rodrigus, P, Rutgers, E J, Klijn, J G, Coebergh, J W

    Published in European journal of cancer (1990) (01-04-1999)
    “…The impact of a family history of breast cancer on the local recurrence (LR) risk after breast-conserving therapy (BCT) was performed within the framework of a…”
    Get full text
    Journal Article
  20. 20